Caudill Cortney
SEC insider (Form 3/4/5 filer). CIK 0002090209. SVP, CHIEF OPERATING OFFICER at HALOZYME THERAPEUTICS, INC. (HALO). 15 reported Form 4/5 transactions since Sep 2024; latest on Mar 10, 2026. Located in SAN DIEGO, CA.
Companies Caudill Cortney has filed insider reports for
- HALOZYME THERAPEUTICS, INC. (HALO): Officer, SVP, CHIEF OPERATING OFFICER
Caudill Cortney
CIK: 0002090209
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
HALOZYME THERAPEUTICS, INC.
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- Mar 10, 2026HALO
HALOZYME THERAPEUTICS, INC.
SaleDirect8.9K shares at avg. $67.64$599K - Mar 10, 2026HALO
HALOZYME THERAPEUTICS, INC.
ExerciseDirect1.5K shares at avg. $33.51$52K - Mar 9, 2026HALO
HALOZYME THERAPEUTICS, INC.
SaleDirect17.9K shares at avg. $67.75$1.2M - Mar 9, 2026HALO
HALOZYME THERAPEUTICS, INC.
SaleDirect2.1K shares at avg. $68.25$143K - Mar 9, 2026HALO
HALOZYME THERAPEUTICS, INC.
ExerciseDirect20K shares at avg. $33.51$670K - Feb 20, 2026HALO
HALOZYME THERAPEUTICS, INC.
Tax PaymentDirect1K shares at avg. $70.98$74K - Feb 20, 2026HALO
HALOZYME THERAPEUTICS, INC.
ExerciseDirect2.7K shares- - Feb 9, 2026HALO
HALOZYME THERAPEUTICS, INC.
AwardDirectPerformance Stock Units
14.8K shares- - Feb 9, 2026HALO
HALOZYME THERAPEUTICS, INC.
AwardDirectOption to Purchase Common Stock
14K shares- - Feb 9, 2026HALO
HALOZYME THERAPEUTICS, INC.
AwardDirectRestricted Stock Units
13K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 10, 2026 | HALO HALOZYME THERAPEUTICS, INC. | Sale | 8,857 | $67.64 | $599,087 | Direct |
| Mar 10, 2026 | HALO HALOZYME THERAPEUTICS, INC. | Exercise | 1,546 | $33.51 | $51,806 | Direct |
| Mar 9, 2026 | HALO HALOZYME THERAPEUTICS, INC. | Sale | 17,900 | $67.75 | $1,212,743 | Direct |
| Mar 9, 2026 | HALO HALOZYME THERAPEUTICS, INC. | Sale | 2,100 | $68.25 | $143,329 | Direct |
| Mar 9, 2026 | HALO HALOZYME THERAPEUTICS, INC. | Exercise | 20,000 | $33.51 | $670,200 | Direct |
| Feb 20, 2026 | HALO HALOZYME THERAPEUTICS, INC. | Tax Payment | 1,037 | $70.98 | $73,606 | Direct |
| Feb 20, 2026 | HALO HALOZYME THERAPEUTICS, INC. | Exercise | 2,666 | - | $0 | Direct |
| Feb 9, 2026 | HALO HALOZYME THERAPEUTICS, INC. | Award Performance Stock Units | 14,751 | - | - | Direct |
| Feb 9, 2026 | HALO HALOZYME THERAPEUTICS, INC. | Award Option to Purchase Common Stock | 14,047 | - | - | Direct |
| Feb 9, 2026 | HALO HALOZYME THERAPEUTICS, INC. | Award Restricted Stock Units | 13,047 | - | - | Direct |
1-10 of 15 transactions